查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2092708

呼吸系統生物製藥市場：按類型、給藥途徑、應用、分銷管道、國家和地區分類－全球產業分析、市場規模、市場佔有率和預測（2026-2033 年）

Respiratory Biologics Market, By Type, By Route of Administration, By Application, By Distribution Channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 403 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，呼吸系統生物製藥市場價值將達到 112.58 億美元，並將在 2026 年至 2033 年期間以 18.4% 的複合年成長率成長。

呼吸系統生物製劑是由活細胞製成的藥物，其靶向導致疾病的潛在免疫和發炎反應，從而幫助治療嚴重的呼吸系統疾病。與主要緩解症狀的傳統療法不同，生物製劑針對導致疾病進展的特定分子或訊號路徑。它們廣泛用於治療重度氣喘、伴隨鼻息肉的慢性鼻竇炎和嗜酸性粒細胞呼吸系統疾病等患者。

呼吸系統生物製藥市場－市場動態

嚴重氣喘和慢性呼吸系統疾病的日益普遍，以及標靶治療的進步，預計將推動市場需求。

呼吸系統生物製藥市場的主要促進因素之一是全球重度氣喘和其他慢性呼吸系統疾病盛行率的不斷上升。儘管使用了傳統的吸入藥物，數百萬患者仍然飽受持續症狀和頻繁急性發作的困擾，這凸顯了對更有效治療方法的需求。世界衛生組織 (WHO) 估計，全球有超過 2 億人患有氣喘。這意味著有大量患者可以從更有效的治療方法中受益。呼吸系統生物製藥透過作用於導致疾病進展的特定免疫和發炎通路，提供了一種針對精準的醫療方法。生物標記檢測、表現型分析和患者分層技術的進步進一步促進了治療的個人化，使醫療專業人員能夠更準確地識別適合生物製藥治療的患者。人們對嚴重呼吸系統疾病的認知不斷提高、診斷能力的提升以及獲得專科護理的機會增加，都在推動呼吸系統生物製藥在主要醫療保健市場的應用。

此外，呼吸系統生物製藥市場成長的關鍵促進因素是針對呼吸系統疾病相關免疫和發炎路徑的新型生物療法的持續研發。製藥公司正大力投資研發，以改善治療效果並擴大核准適應症範圍。針對胸腺間質淋巴細胞生成因子 (TSLP)、IL-33 等生物標記和介質以及其他主要發炎路徑的新型療法，正在為複雜呼吸系統疾病患者拓展治療選擇。此外，生物製藥的應用範圍正從重度氣喘擴展到慢性阻塞性肺病(COPD) 和其他嗜酸性粒細胞呼吸系統疾病。

呼吸系統生物製藥市場－市場區隔分析：

全球呼吸系統生物製藥市場按類型、給藥途徑、應用、分銷管道和地區進行細分。

根據類型，呼吸系統生物製藥市場可分為五大類：胜肽類和蛋白質、疫苗、單株抗體、RNAi療法及其他。其中，單株抗體領域是呼吸系統生物製藥市場的主要驅動力，該領域在治療嚴重呼吸系統疾病（如重度氣喘、伴隨鼻息肉的嗜酸性粒細胞和嗜酸性粒細胞性呼吸系統疾病）方面展現出較高的臨床療效。這些生物製藥針對驅動疾病進展的特定免疫和發炎通路，與傳統療法相比，具有更高的精確度和療效。

呼吸系統生物製藥市場—區域分析

北美憑藉其完善的醫療保健體系、先進的生物製藥高滲透率以及對嚴重呼吸系統疾病的高度重視，在呼吸系統生物製藥市場中扮演著舉足輕重的角色。該地區持續增加對呼吸系統疾病研究的投入，不斷為患者提供創新療法，並日益普及個人化醫療方法，這些都為其發展提供了持續的動力。歐洲也佔據較大的市場佔有率，這主要得益於診斷率的提高和生物製藥產品接受度的提升。歐洲的醫療保健系統越來越重視能夠更好地控制疾病並改善長期健康結果的先進治療方案。此外，完善的法律規範、不斷累積的臨床證據以及醫生對生物製藥日益增強的信心，也進一步推動了歐洲市場的成長。

目錄

第1章：呼吸系統生物製藥市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：呼吸系統生物製藥的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：呼吸系統生物製藥產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章 呼吸系統生物製藥市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：呼吸系統生物製藥市場趨勢

  • 呼吸系統生物製藥市佔率分析，2025年
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 呼吸系統生物製藥市場：依類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按類型
    • 胜肽和蛋白質
    • 疫苗
    • 單株抗體
    • 基於RNAi的療法
    • 其他

第8章 呼吸系統生物製藥市場：依給藥途徑分類

  • 概述
    • 按給藥途徑分類的市佔率分析
    • 皮下
    • 靜脈

第9章 呼吸系統生物製藥市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 氣喘
    • COPD
    • 囊腫纖維化
    • 新冠肺炎相關疾病
    • 過敏性呼吸系統疾病
    • 其他

第10章 呼吸系統生物製藥市場：依分銷管道分類

  • 概述
    • 基於細分市場的市場佔有率分析：按分銷管道分類
    • 醫院藥房
    • 零售藥房
    • 網路藥房

第11章 呼吸系統生物製藥市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他中東和非洲國家

第12章：主要供應商分析：呼吸系統生物製藥產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • AstraZeneca
    • Sanofi
    • GSK
    • Regeneron Pharmaceuticals
    • Amgen
    • Teva Pharmaceutical Industries
    • Novartis
    • Roche
    • Merck & Co.
    • Johnson & Johnson
    • AbbVie
    • Pfizer
    • Boehringer Ingelheim
    • Ocugen Inc.
    • CanSino Biologics
    • Vertex Pharmaceuticals
    • Others

第13章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV7007

Respiratory Biologics Market size was valued at USD 11,205.8 Million in 2025, expanding to a CAGR of 18.4% from 2026 to 2033.

Respiratory biologics are medicines made from living cells that help treat severe respiratory diseases by targeting the underlying immune and inflammatory processes that cause the condition. Biologics are different from traditional therapies that mostly treat symptoms. They target specific molecules or pathways that cause the disease to progress. They are commonly used in patients with severe asthma, chronic rhinosinusitis with nasal polyps, eosinophilic respiratory disorders, etc.

Respiratory Biologics Market- Market Dynamics

Rising prevalence of severe asthma, chronic respiratory disorders and developments in targeted therapies are expected to propel market demand

One of the primary drivers of the respiratory biologics market is the rising prevalence of severe asthma and other chronic respiratory diseases worldwide. Despite the use of conventional inhaled medications, millions of patients continue to experience persistent symptoms and frequent exacerbations, highlighting the need for more effective treatment options. The World Health Organization (WHO) estimates that more than 200 million people worldwide suffer from asthma. This highlights the huge number of patients that can potentially benefit from improved therapies. Respiratory biologics provide a targeted, precision-medicine approach by addressing specific immune and inflammatory pathways that contribute to disease progression. Advances in biomarker testing, phenotyping, and patient stratification have further enhanced treatment personalization, allowing healthcare professionals to identify suitable candidates for biologic therapy more accurately. Growing awareness of severe respiratory diseases, improved diagnostic capabilities, and increasing access to specialized care are collectively supporting the broader adoption of respiratory biologics across major healthcare markets.

Further, a significant factor driving the growth of the respiratory biologics market is the ongoing development of innovative biologic therapies that target a wider range of immune and inflammatory pathways involved in respiratory diseases. Pharmaceutical companies are making substantial investments in research and development to enhance treatment outcomes and broaden the scope of approved indications. New therapies targeting biomarkers and mediators such as thymic stromal lymphopoietin (TSLP), IL-33, and other key inflammatory pathways are expanding treatment possibilities for patients with complex respiratory conditions. Additionally, the application of biologics is extending beyond severe asthma to include diseases such as chronic obstructive pulmonary disease (COPD) and other eosinophilic respiratory disorders.

Respiratory Biologics Market- Segmentation Analysis:

The Global Respiratory Biologics Market is segmented on the basis of Type, Route of Administration, Application, Distribution Channel, and Region.

The market is divided into five categories based on Type: peptides and proteins, vaccines, monoclonal antibodies, RNAi-based therapeutics, others. The respiratory biologics market is majorly driven by the monoclonal antibodies segment due to their strong clinical effectiveness in treating severe respiratory conditions such as severe asthma, chronic rhinosinusitis with nasal polyps, and eosinophilic respiratory diseases. These biologics target specific immune and inflammatory pathways that drive disease progression with a greater degree of precision and efficacy than conventional therapies.

Respiratory Biologics Market- Geographical Insights

North America is a key contributor in the Respiratory Biologics Market, owing to the well-established healthcare system, high adoption of advanced biologic therapies, and high awareness regarding severe respiratory conditions. Ongoing investments in respiratory disease research, patient access to innovative treatments and the growing adoption of personalized medicine approaches in the region continue to benefit the region. Europe also accounts for a significant share of the market, driven by improving diagnosis rates and increasing acceptance of targeted biologic therapies. Healthcare systems across the region are placing greater emphasis on advanced treatment options that can deliver better disease control and long-term health outcomes. Supportive regulatory frameworks, expanding clinical evidence, and growing physician confidence in biologic treatments are further contributing to market growth across European countries.

Norway Respiratory Biologics Market- Key Insights

In Europe, Norway is an established and growing market for respiratory biologics, driven by its well-developed healthcare system, strong healthcare investments, and increasing emphasis on personalized medicine. The country has adopted advanced diagnostic techniques, including biomarker testing and patient phenotyping, which enable healthcare professionals to identify individuals who are most likely to benefit from targeted biologic therapies. Norway also offers broad access to specialist respiratory care and innovative treatment options for patients with severe respiratory diseases. Supported by a favorable reimbursement environment and a strong focus on improving patient outcomes, the adoption of respiratory biologics continues to increase across the country.

Respiratory Biologics Market- Competitive Landscape:

Leading pharmaceutical companies compete in the extremely dynamic respiratory biologics market by owing to the ongoing innovation, product development, and portfolio growth. The goal of market participants is to develop targeted therapies that increase patient convenience, treatment precision, and clinical results. Research initiatives examining novel immunological and inflammatory mechanisms linked to respiratory disorders are receiving substantial funding. Additionally, businesses are bolstering their market position through acquisitions, licensing deals, and strategic alliances that increase their capacity to treat respiratory conditions.

Recent Developments:

In May 2025, Sanofi expanded its respiratory biologics portfolio by presenting new clinical data for Dupixent at the American Thoracic Society (ATS) International Conference. The company reported positive Phase III findings from the BOREAS and NOTUS studies, demonstrating improvements in lung function.

In May 2025, GSK strengthened its respiratory biologics portfolio after the U.S. FDA approved Nucala (mepolizumab) as an add-on maintenance treatment for adults with eosinophilic chronic obstructive pulmonary disease (COPD).

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RESPIRATORY BIOLOGICS MARKET KEY PLAYERS

  • AstraZeneca
  • Sanofi
  • GSK
  • Regeneron Pharmaceuticals
  • Amgen
  • Teva Pharmaceutical Industries
  • Novartis
  • Roche
  • Merck & Co.
  • Johnson & Johnson
  • AbbVie
  • Pfizer
  • Boehringer Ingelheim
  • Ocugen Inc.
  • CanSino Biologics
  • Vertex Pharmaceuticals
  • Others

GLOBAL RESPIRATORY BIOLOGICS MARKET, BY TYPE- MARKET ANALYSIS, 2020-2033

  • Peptides and proteins
  • Vaccines
  • Monoclonal antibodies
  • RNAi-based therapeutics
  • Others

GLOBAL RESPIRATORY BIOLOGICS MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2020-2033

  • Subcutaneous
  • Intravenous

GLOBAL RESPIRATORY BIOLOGICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2020-2033

  • Asthma
  • COPD
  • Cystic Fibrosis
  • COVID-19 Disorders
  • Allergic Respiratory Diseases
  • Others

GLOBAL RESPIRATORY BIOLOGICS MARKET, BY DISTRIBUTION CHANNEL- MARKET ANALYSIS, 2020-2033

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

GLOBAL RESPIRATORY BIOLOGICS MARKET, BY REGION- MARKET ANALYSIS, 2020-2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Respiratory Biologics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Respiratory Biologics Market Snippet by Type
    • 2.1.2. Respiratory Biologics Market Snippet by Route of Administration
    • 2.1.3. Respiratory Biologics Market Snippet by Application
    • 2.1.4. Respiratory Biologics Market Snippet by Distribution Channel
    • 2.1.5. Respiratory Biologics Market Snippet by Country
    • 2.1.6. Respiratory Biologics Market Snippet by Region
  • 2.2. Competitive Insights

3. Respiratory Biologics Key Market Trends

  • 3.1. Respiratory Biologics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Respiratory Biologics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Respiratory Biologics Market Opportunities
  • 3.4. Respiratory Biologics Market Future Trends

4. Respiratory Biologics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Respiratory Biologics Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Respiratory Biologics Market Landscape

  • 6.1. Respiratory Biologics Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Respiratory Biologics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2025 & 2033 (%)
    • 7.1.2. Peptides and proteins
    • 7.1.3. Vaccines
    • 7.1.4. Monoclonal antibodies
    • 7.1.5. RNAi-based therapeutics
    • 7.1.6. Others

8. Respiratory Biologics Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2025 & 2033 (%)
    • 8.1.2. Subcutaneous
    • 8.1.3. Intravenous

9. Respiratory Biologics Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 9.1.2. Asthma
    • 9.1.3. COPD
    • 9.1.4. Cystic Fibrosis
    • 9.1.5. COVID-19 Disorders
    • 9.1.6. Allergic Respiratory Diseases
    • 9.1.7. Others

10. Respiratory Biologics Market - By Distribution Channel

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Distribution Channel, 2025 & 2033 (%)
    • 10.1.2. Hospital Pharmacies
    • 10.1.3. Retail Pharmacies
    • 10.1.4. Online Pharmacies

11. Respiratory Biologics Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Respiratory Biologics Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Respiratory Biologics Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Respiratory Biologics Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Respiratory Biologics Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Respiratory Biologics Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Type, 2020 - 2033 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2020 - 2033 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Distribution Channel, 2020 - 2033 (US$ Million)

12. Key Vendor Analysis- Respiratory Biologics Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. AstraZeneca
    • 12.2.2. Sanofi
    • 12.2.3. GSK
    • 12.2.4. Regeneron Pharmaceuticals
    • 12.2.5. Amgen
    • 12.2.6. Teva Pharmaceutical Industries
    • 12.2.7. Novartis
    • 12.2.8. Roche
    • 12.2.9. Merck & Co.
    • 12.2.10. Johnson & Johnson
    • 12.2.11. AbbVie
    • 12.2.12. Pfizer
    • 12.2.13. Boehringer Ingelheim
    • 12.2.14. Ocugen Inc.
    • 12.2.15. CanSino Biologics
    • 12.2.16. Vertex Pharmaceuticals
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us